Mark Hancock
CIK 2014361 · Co Fndr; Exec V Chair · last filed 2026-11-04
Mark Hancock is a Co Fndr; Exec V Chair who has filed 33 SEC Form 4 insider transactions across 1 company since 2024. The most recent filing shows the insider sold $9.4M of PACS on Nov 4, 2026. Across all open-market trades the lifetime net is −$379.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.08B across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
PACS price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
262 N. UNIVERSITY AVENUE
FARMINGTON, UT 84025
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PACS | Director | 62,818,884 | $49.10 | $3.08B | -$379.46M | 16 | 2026-11-04 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-11-04 | PACS | Sell (S) | −186,696 | -$9.42M | EDGAR |
| 2026-11-04 | PACS | Notice (144) | −186,696 | -$9.42M | EDGAR |
| 2026-10-30 | PACS | Sell (S) | −13,304 | -$666.2K | EDGAR |
| 2026-10-29 | PACS | Notice (144) | −4,280 | -$214.1K | EDGAR |
| 2026-10-28 | PACS | Notice (144) | −9,024 | -$452.1K | EDGAR |
| 2026-09-15 | PACS | Notice (144) | −155,682 | -$6.61M | EDGAR |
| 2026-09-15 | PACS | Sell (S) | −300,000 | -$13.04M | EDGAR |
| 2026-09-15 | PACS | Notice (144) | −144,318 | -$6.43M | EDGAR |
| 2026-08-27 | PACS | Gift (G) | −88,000 | $0 | EDGAR |
| 2026-07-16 | PACS | Sell (S) | −13,628 | -$613.8K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.